Charles River Laboratories (CRL)

Currency in USD
167.81
-1.40(-0.83%)
Closed·
167.810.00(0.00%)
·

CRL Earnings

Latest Release
Nov 05, 2025
EPS / Forecast
2.43 / 2.34
Revenue / Forecast
1.00B / 987.43M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
12/2025--/2.34--/986.28M----Free Sign Up
09/20252.43/2.341B/987.43M+3.85%+1.27%Free Sign Up
06/20251.06/2.51.03B/984.86M-57.6%+4.58%Free Sign Up
03/20250.5/2.09984.17M/941.47M-76.08%+4.54%Free Sign Up
12/20242.66/2.541B/985.18M+4.72%+1.5%Free Sign Up
09/20242.59/2.421.01B/976M+7.02%+3.48%Free Sign Up
06/20242.8/2.41.03B/1.02B+16.67%+0.98%Free Sign Up
03/20242.27/2.061.01B/992.31M+10.19%+1.78%Free Sign Up
12/20232.46/2.411.01B/991.25M+2.07%+1.89%Free Sign Up
09/20232.72/2.361.03B/1B+15.25%+3%Free Sign Up

All numbers in USD

Charles River Laboratories Earnings Call Summary for Q3/2025

  • Charles River Labs exceeded Q3 2025 forecasts with $2.43 EPS and $1B revenue, yet stock fell 6.66% amid 0.5% organic revenue decline and 20bps operating margin contraction
  • Company announced $225M cost-saving measures by 2026 while maintaining full-year non-GAAP EPS guidance between $10.10-$10.30 with projected 1.5-2.5% organic revenue decline
  • CEO Jim Foster highlighted the company's 'scientifically differentiated portfolio' positioned to capitalize on biopharmaceutical landscape opportunities
  • Improved biotech funding and decreased cancellation rates signal potential market recovery, though investors remain cautious about growth prospects
  • Management implemented strategic pricing and increased flexibility in response to market demands while pursuing acquisition opportunities for 2026 growth
Last Updated: 05/11/2025, 17:34
Read Full Transcript

FAQ

What Is Charles River Laboratories's Earnings Per Share (TTM)?

The Charles River Laboratories EPS (TTM) is -1.67.

When Is The Next Charles River Laboratories Earnings Date?

Charles River Laboratories will release its next earnings report on 17 Feb 2026.

What Is Charles River Laboratories’s Revenue Forecasts For Upcoming Quarters?

Charles River Laboratories’s revenue forecast is 986.28M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.